X
    學術可視化工作室RC   登錄   提交文稿
學術英文編修

JOURNAL OF CONTROLLED RELEASE

期刊標題檢索 J CONTROL RELEA 最新評論: The content of the submission is new in terms of technical aspects, ma... (2024-05-31)


期刊名稱:   ISSN:   主題領域:   影響因子範圍: -
索引:   類別:   開放訪問:   排序方式:

[JOURNAL OF CONTROLLED RELEASE]您好,您是該頁面的第 264763 位訪客。

期刊簡介
期刊名稱JOURNAL OF CONTROLLED RELEASE JOURNAL OF CONTROLLED RELEASE
LetPub Score
9.1
50 ratings
Rate

Reputation
9.8

Influence
8.8

Speed
8.7

期刊簡稱J CONTROL RELEASE
ISSN0168-3659
E-ISSN1873-4995
h-index237
CiteScore
CiteScoreSJRSNIPCiteScore Rank
18.502.1571.559
Subject fieldQuartilesRankPercentile
Category: Pharmacology, Toxicology and Pharmaceutics
Subcategory: Pharmaceutical Science
Q13 / 183

自引率 (2023-2024)3.80%自引率趨勢
掲載範囲
The Journal of Controlled Release (JCR) publishes high-quality research articles in the broad field of delivery science and technology. This includes drug delivery systems and all aspects of formulations, such as physicochemical and biological properties of drugs, design and characterization of dosage forms, release mechanisms, in vivo testing, and formulation research and development in the disciplines of pharmaceutical, diagnostic, agricultural, environmental, cosmetic, and food industries. Manuscripts that advance fundamental understanding of principles and/or demonstrate advantages of novel technologies in safety and efficacy over current clinical standards will be given priority. Each issue has the cover story highlighting the significance of a selected article published in the issue. At the end of each quarter, the JCR editors select "The Editors' Choice" from the published research articles.
官方網站https://www.journals.elsevier.com/journal-of-controlled-release
在線稿件提交https://www.editorialmanager.com/COREL
開放訪問No
出版商Elsevier
主題領域医学
出版國/地區NETHERLANDS
發行頻率月2回刊行
創刊年1984
每年文章數645每年文章數趨勢
黃金OA百分比22.04%
Web of Science 四分位
2023-2024
WOS Quartile: Q1

CategoryEditionJIF QuartileJIF RankingJIF Percentage
CHEMISTRY, MULTIDISCIPLINARYSCIEQ126/230
PHARMACOLOGY & PHARMACYSCIEQ112/354
索引 (SCI or SCIE)Science Citation Index
Science Citation Index Expanded
鏈接到PubMed Central (PMC)https://www.ncbi.nlm.nih.gov/nlmcatalog?term=0168-3659%5BISSN%5D
平均審稿時間 *來自出版商的數據:
來自作者的數據: About 2.6 month(s)
來自Elsevier的數據: Average 6.2 Week(s)
競爭力 *來自作者的數據: 50%
在線文章發布時間來自Elsevier的數據: Average 6.2 Week(s)
參考鏈接
相關期刊 【JOURNAL OF CONTROLLED RELEASE】CiteScore趨勢
自引率趨勢 每年文章數趨勢
作者評論
*所有的審稿過程指標,如接受率和審稿速度,僅限於用戶提交的稿件。因此,這些指標可能無法準確反映期刊的競爭力或速度。
  • 同一學科的期刊
  • CiteScore趨勢
  • 自引率趨勢
  • 每年文章數趨勢
  •  
    學科內的可信期刊 影響因子
    CHEMICAL REVIEWSH-index: 609

    CiteScore: 106.00
    CHEMICAL SOCIETY REVIEWSH-index: 432

    CiteScore: 80.80
    Nature ChemistryH-index: 187

    CiteScore: 29.60
    ACCOUNTS OF CHEMICAL RESEARCHH-index: 354

    CiteScore: 31.40
    ANGEWANDTE CHEMIE-INTERNATIONAL EDITIONH-index: 482

    CiteScore: 26.60
    Journal of the American Chemical SocietyH-index: 542

    CiteScore: 24.40
    CHINESE CHEMICAL LETTERSH-index: 41

    CiteScore: 14.10
    GREEN CHEMISTRYH-index: 186

    CiteScore: 16.10
    ULTRASONICS SONOCHEMISTRYH-index: 109

    CiteScore: 15.80
    ChemSusChemH-index: 130

    CiteScore: 15.80
    學科內最受檢索的期刊 頁面查看次數
    CHEMICAL COMMUNICATIONS1241600
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES1241403
    ANGEWANDTE CHEMIE-INTERNATIONAL EDITION1079745
    Journal of the American Chemical Society839528
    NEW JOURNAL OF CHEMISTRY664938
    GREEN CHEMISTRY663366
    CHEMISTRY-A EUROPEAN JOURNAL500506
    CHINESE CHEMICAL LETTERS496257
    ChemSusChem467808
    CRYSTENGCOMM369291
  •  

    JOURNAL OF CONTROLLED RELEASE JOURNAL OF CONTROLLED RELEASE
    明年預測:
    穩步上升 無變化 逐步下降  刷新
  •  

     
  •  

     


首頁    上一頁    1    2    3    4    下一頁    末頁  (頁
/4)
  [JOURNAL OF CONTROLLED RELEASE] 的評論撰寫評論
作者: 半π


領域: 医学
審稿時間: 2.0 month(s)
結果: 拒稿


撰寫評論

2024-05-31 08:38:27 評論於
The content of the submission is new in terms of technical aspects, material construction strategies, and the effects of formulation use. After submission, two of the three reviewers suggested minor revisions, but the third reviewer harshly criticized the manuscript, saying it was all rubbish, and then said, "Using cellulose acetate as a drug carrier, and cellulose acetate cannot degrade, so it cannot be used for oral nanodrugs. The manuscript should be rejected directly." The Korean-American female editor at Stanford University also rejected the manuscript because of this. Malicious reviewers (from the mainland) + ignorant editors have made me lose my desire to argue. The journal circle is deep and unpredictable; I must henceforth be a passerby!
(0) 讚! | 半π

作者: 豆子


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2024-05-21 10:30:43 評論於
How did the article turn out in the end?
(0) 讚! | 豆子

作者: asd3204


領域: 医学
審稿時間: 4.0 month(s)
結果: 拒稿


撰寫評論

2024-05-18 20:58:57 評論於
This has already been rejected, there is no need to hold on to any illusions, DIP before the submission has no exceptions
(1) 讚! | asd3204

作者: Kingsley791


領域: 医学
審稿時間: 1.0 month(s)
結果: 直接被接受


撰寫評論

2024-05-14 16:17:38 評論於
Will the decision continue to be in process before under review? Hahaha
(0) 讚! | Kingsley791

作者: Kingsley791


領域: 医学
審稿時間: 1.0 month(s)
結果: 直接被接受


撰寫評論

2024-05-14 16:16:41 評論於
First-time submission with editor, decision in process for 7 days now. Haha, is this the process of rejection or just the state before the reviewer accepts the manuscript? Haha, keep going, good luck
(0) 讚! | Kingsley791

作者: Kingsley791


領域: 医学
審稿時間: 1.0 month(s)
結果: 直接被接受


撰寫評論

2024-05-09 16:57:56 評論於
Basking in happiness will bring you good luck
(0) 讚! | Kingsley791

作者: Kingsley791


領域: 医学
審稿時間: 1.0 month(s)
結果: 直接被接受


撰寫評論

2024-05-09 16:57:00 評論於
Soak up the joy and cheer yourself on!
(0) 讚! | Kingsley791

作者: ZNNBB


領域: 工程技术
審稿時間: 1.0 month(s)
結果: 修改後接受


撰寫評論

2024-05-02 20:10:04 評論於
Submitted in early February, received the first review result in about four weeks. The revised manuscript was received three weeks after submission. The editorial process was efficient, and the reviewers' comments were very professional
(0) 讚! | ZNNBB

作者: 四象初桃


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2024-04-23 09:37:50 評論於
Hello, I would like to ask about the status of our submission. It has been a week and it still shows as "Submitted to Journal." Is this normal?
(0) 讚! | 四象初桃

作者: 醇菌


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2024-04-14 23:45:15 評論於
Submitted on April 1st
Still with editor on April 14
So slow
(0) 讚! | 醇菌

作者: yeyeyezi


領域: 医学
審稿時間: 1.0 month(s)
結果: 修改後接受


撰寫評論

2024-03-17 23:09:24 評論於
Submission at the end of July, acceptance in early March.
The editorial process is very fast. Reviewers are very serious and responsible, asking many questions and requiring additional experiments. Replying to the reviewers' comments feels like writing another article
(0) 讚! | yeyeyezi

作者: MELODYS


領域: 医学
審稿時間: 2.0 month(s)
結果: 修改後接受


撰寫評論

2024-03-17 20:15:47 評論於
2023.09.25 submit
2023.11.16 major revision
2024.01.23 resubmit
2024.02.22 minor re
2024.02.25 resubmit
2024.03.12 accepted
(0) 讚! | MELODYS

作者: Renata Bronte


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2024-01-23 10:58:04 評論於
Hello, how have you been doing lately?
(0) 讚! | Renata Bronte

作者: 落木萧萧~


領域: 医学
審稿時間: 1.0 month(s)
結果: 修改後接受


撰寫評論

2024-01-18 13:27:04 評論於
2023.10.26 submit
2023.11.19 revise
2024.01.03 resubmit
2024.01.15 accept
2024.01.16 proof
(2) 讚! | 落木萧萧~

作者: 夏Longqing


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2023-12-16 20:24:29 評論於
Hey, have you received the follow-up?
(0) 讚! | 夏Longqing

作者: 天行健01


領域: 化学
審稿時間: 2.0 month(s)
結果: 待定&不明


撰寫評論

2023-12-08 00:52:12 評論於
9.15 submit
9.22 under review
11.14 review complete
11.29 revise
The editor did not request major revisions, but there were a total of over ten questions from two reviewers, all of them very professional and detailed. One of the reviewers suggested changing one of the experiments. I am in a hurry to graduate. Does anyone know if it is possible to explain to the reviewer without redoing the experiment?
(0) 讚! | 天行健01

作者: 夏Longqing


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2023-11-30 20:42:46 評論於
Can you please tell me if the next state after "editor invited" is "under reviewer" or it continues to be "with editor"? I am also in this situation and I am not sure if it means a change in editors or for another reason
(0) 讚! | 夏Longqing

作者: 是张小花


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2023-10-04 15:42:50 評論於
Submitted to journal on 3rd October 2023
(0) 讚! | 是张小花

作者: 川穹


領域: 医学
審稿時間: 1.0 month(s)
結果: 待定&不明


撰寫評論

2023-09-27 22:21:37 評論於
Excuse me, has the status been updated behind? I am also like this now
(0) 讚! | 川穹

作者: 中原向雪


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2023-08-27 16:24:45 評論於
Has it changed later?
(0) 讚! | 中原向雪

作者: 中原向雪


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2023-08-21 17:24:31 評論於
How are you doing, OP?
(0) 讚! | 中原向雪

作者: shenxin


領域: 工程技术
審稿時間: 1.0 month(s)
結果: 修改後接受


撰寫評論

2023-07-24 16:30:15 評論於
4.16 submit - Submitted on April 16th
4.17 under reviews - Undergoing review on April 17th
5.18 major revision - Requires significant revision on May 18th
7.20 resubmit - Needs to be resubmitted on July 20th
7.21 accept - Accepted on July 21st
(0) 讚! | shenxin

作者: 辉夜辰皓


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2023-07-20 20:41:06 評論於
Not necessary
(0) 讚! | 辉夜辰皓

作者: undefined


領域: 医学
審稿時間: 1.0 month(s)
結果: 拒稿


撰寫評論

2023-07-14 12:08:35 評論於
Does Battle have any follow-up results?
(0) 讚! | undefined

作者: mzi


領域: 工程技术
審稿時間: 2.0 month(s)
結果: 修改後接受


撰寫評論

2023-07-11 17:38:43 評論於
The article was submitted in early April and received the first round of comments in late May. It was revised in early June and received the second round of comments in mid-June. The article was then revised again in late June and accepted in early July. The first round of comments focused more on the content, and we provided explanations for each point in our response. The second round of comments emphasized the formatting, and the reviewers were professional and responsible.
(0) 讚! | mzi

首頁    上一頁    1    2    3    4    下一頁    末頁  (頁
/4)

開始撰寫 [JOURNAL OF CONTROLLED RELEASE] 的評論:





Contact us

Contact us  

Your name*

Your email*

Your message*

Please fill in all fields and provide a valid email.

Security Code*